<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01861639</url>
  </required_header>
  <id_info>
    <org_study_id>WP1P003</org_study_id>
    <nct_id>NCT01861639</nct_id>
  </id_info>
  <brief_title>Stability of rTMS on Cognition and Brain Networks on Healthy Subjects.</brief_title>
  <official_title>Effect of Repetitive Transcranial Magnetic Stimulation (rTMS) on Cognition and Brain Networks in Healthy Subjects in 2 Sessions 15 Days Apart</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Qualissima</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Qualissima</source>
  <brief_summary>
    <textblock>
      Episodic and working memory processes are the most affected cognitive domains in Alzheimer's
      Disease (AD) and its early stage, Mild Cognitive Impairment (MCI).

      Transcranial Magnetic Stimulation (TMS) is a unique tool to interfere with cognitive
      processes by inducing &quot;virtual and transient lesions&quot;, mimicking those observed in MCI. It
      has proven repeatedly its capacity to interfere with encoding-retrieval memory task. However,
      to date, only few imaging data exist on the cerebral pathways involved in encoding memory
      task. Moreover, the stability of TMS effects over time remains to be investigated. If proven
      to be a stable interfering challenge, TMS could be used to investigate the potential
      restoring effect of new medication in AD.

      The study is the pilot study of a larger clinical trial which aims to prove the utility of
      rTMS as a potential model for prediction of clinical efficacy using a combination of
      cognitive and neuroimaging endpoints.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Timeframe of the IMI project couldn't be expended
  </why_stopped>
  <start_date>May 2013</start_date>
  <completion_date type="Actual">December 2015</completion_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Outputs of the memory task</measure>
    <time_frame>up to Day 15</time_frame>
    <description>outputs: number of correct answers during the retrieval event-related task (Hit rate) and the rate of false recognition of novel pictures (False Alarms rate).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>CANTAB task</measure>
    <time_frame>Day 1 and Day 15</time_frame>
    <description>CANTAB / Rapid Visual Information Processing (RVIP)
CANTAB / Spatial Working Memory (SWM)
CANTAB / Paired Associates Learning (PAL)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Gene expression</measure>
    <time_frame>Day 1</time_frame>
    <description>Interest genes expression will be investigated depending on the impact of TMS on behavioral and functional brain responses.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Imaging</measure>
    <time_frame>Day1 and Day 15</time_frame>
    <description>Functional MRI (Barcelona): modifications will be highlighted by changes in Blood Oxydation level Dependence (BOLD)signal patterns
EEG (Marseille): modifications will be highlighted by changes in EEG markers</description>
  </secondary_outcome>
  <number_of_arms>8</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ineffective rTMS</intervention_name>
    <description>A 20Hz repetitive transcranial magnetic stimulation (rTMS) will be applied for 900 ms with an intensity of 90% of motor threshold. Active stimulation will be applied on the L-DLPFC compared to an ineffective stimulation.</description>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active TBS</intervention_name>
    <description>A continuous Theta-Burst Stimulation (cTBS) protocol will be applied over the L-DLPFC. Three stimuli at 50Hz, 80% of individual Motor Threshold will be repeated every 200ms for 40sec</description>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham TBS</intervention_name>
    <description>A Sham stimulation will be applied over the L-DLPFC. a placebo coil will be used.</description>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fMRI</intervention_name>
    <description>Functional MRI data will be acquired during the performance of the memory task. Functional data will be acquired with a blood oxygenation level dependant (BOLD) contrast sensitive gradient echo, T2*-weighted echo-planar imaging sequence</description>
    <arm_group_label>ineffective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EEG</intervention_name>
    <description>EEG will be coupled with task performance in an event-related manner to be able to isolate brain activity of each type of stimuli presented. EEG imaging data will be acquired during the memory task.</description>
    <arm_group_label>ineffective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>ineffective rTMS - Sham TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Effective rTMS</intervention_name>
    <description>A 20Hz repetitive transcranial magnetic stimulation (rTMS) will be applied for 900 ms with an intensity of 90% of motor threshold. Active stimulation will be applied on the L-DLPFC compared to an effective stimulation.</description>
    <arm_group_label>Effective rTMS - Active TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - fMRI</arm_group_label>
    <arm_group_label>Effective rTMS - Active TBS - EEG</arm_group_label>
    <arm_group_label>Effective rTMS - Sham TBS - EEG</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male subjects aged between 18 and 40 years-old inclusive.

          -  Education level: at least secondary.

          -  Right-handed (Edinburgh Handedness Inventory).

          -  The subjects are in good health on the basis of the medical interview (medical
             history, symptoms), the physical examination and vital signs.

          -  No history of psychiatric disorders (assessed by Structured Clinical Interview for DSM
             IV Disorders (SCID) for Barcelona and by the Mini International Neuropsychiatric
             Interview (MINI) for Marseille).

          -  No history of neurological disorders

          -  No history of concussion (cranial or facial trauma) without or with loss of
             consciousness.

          -  Subject without history of brain disease (severe brain trauma, stroke, cerebral
             tumor...).

          -  Subject without lesion on MRI.

          -  Subject without abnormal electrical activities on standard clinical EEG.

          -  No history of drug or alcohol abuse.

          -  No smoker or ≤ 5 cg/ day.

          -  The subject can complete the neuropsychological test battery during the training
             session.

          -  Subject without contraindication to MRI.

          -  The subject is able to read and understand the Information Form and comply with the
             protocol instructions and restrictions.

          -  The subject is covered by a social insurance.

          -  The subject has provided written informed consent.

        Exclusion Criteria:

          -  History or presence of psychiatric illness (Psychiatric interview).

          -  History or presence of neurologic illness.

          -  The subject, in the opinion of the investigator, is unlikely to comply with the study
             protocol or is unsuitable for any other reason.

          -  The subject participates in another clinical trial or is still being within a washout
             period of 1 month since last taking of a previous clinical trial, or subjects who have
             received more than 4500 Euros in the previous 12 months for participating in clinical
             trials.

          -  Presence of metallic objects within the body.

          -  Subjects with pacemaker.

          -  Claustrophobia.

          -  Individual and familial history of epileptic seizure.

          -  Any medication listed (see annexe) in the safety guidelines published by the Safety of
             TMS Consensus Group (Rossi et al., 2009) will be forbidden.

          -  Subject with a correct hit rate during the retrieval session of the memory task
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Bartrés-Faz</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut d'Investigacions Biomèdiques August Pi i Sunyer</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christine Audebert</last_name>
    <role>Principal Investigator</role>
    <affiliation>CIC-CPCET</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cic-Cpcet</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>IDIBAPS</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 16, 2013</study_first_submitted>
  <study_first_submitted_qc>May 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 23, 2013</study_first_posted>
  <last_update_submitted>April 18, 2016</last_update_submitted>
  <last_update_submitted_qc>April 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

